Starling Oncology, Inc. Increase (Decrease) in Accounts Receivable
Starling Oncology, Inc. (STLN) reported Increase (Decrease) in Accounts Receivable of $7.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Starling Oncology, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $8.21M, a 2.89% increase year-over-year.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$864.00K, a 187.72% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$641.00K.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $3.98M, a 720.62% increase year-over-year.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $12.31M, a 105.99% increase from fiscal 2024.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $5.97M, a 30.92% increase from fiscal 2023.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $4.56M, a 77.50% decline from fiscal 2022.
- Starling Oncology, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $20.29M, a 824.15% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.35M 10-Q · filed 2026-08-06 | $6.71M derived: sum of 3 quarters · filed 2026-08-06 | $10.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$864.00K 10-Q · filed 2026-05-07 | -$1.50M derived: sum of 2 quarters · filed 2026-05-07 | $2.48M derived: sum of 3 quarters · filed 2026-05-07 | $10.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.34M derived: sum of 2 quarters · filed 2026-03-12 | $11.32M derived: sum of 3 quarters · filed 2026-08-06 | $12.31M 10-K · filed 2026-03-12 |
| 2025-09-30 | $3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.96M derived: sum of 2 quarters · filed 2026-08-06 | $12.95M 10-Q · filed 2025-11-13 | $6.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.97M 10-Q · filed 2026-08-06 | $2.80M derived: sum of 3 quarters · filed 2026-08-06 | $3.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $985.00K 10-Q · filed 2026-05-07 | -$5.18M derived: sum of 2 quarters · filed 2026-05-07 | -$4.70M derived: sum of 3 quarters · filed 2026-05-07 | -$9.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$5.68M derived: sum of 2 quarters · filed 2026-03-12 | -$10.43M derived: sum of 3 quarters · filed 2026-03-12 | $5.97M 10-K · filed 2026-03-12 |
| 2024-09-30 | $485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.26M derived: sum of 2 quarters · filed 2025-11-13 | $12.14M 10-Q · filed 2025-11-13 | $8.05M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $11.66M 10-Q · filed 2025-08-13 | $7.56M derived: sum of 3 quarters · filed 2025-08-13 | $9.64M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $16.40M 10-Q · filed 2025-05-14 | $12.31M derived: sum of 2 quarters · filed 2025-05-14 | $14.39M derived: sum of 3 quarters · filed 2025-05-14 | $14.82M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$2.01M derived: sum of 2 quarters · filed 2025-03-26 | -$1.58M derived: sum of 3 quarters · filed 2025-03-26 | $4.56M 10-K · filed 2025-03-26 |
| 2023-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.52M derived: sum of 2 quarters · filed 2024-11-13 | $8.66M 10-Q · filed 2024-11-13 | $13.73M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $6.58M 10-Q · filed 2024-08-13 | $11.65M derived: sum of 3 quarters · filed 2024-08-13 | $17.66M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $6.14M 10-Q · filed 2024-05-14 | $11.21M derived: sum of 2 quarters · filed 2024-05-14 | $17.23M derived: sum of 3 quarters · filed 2024-05-14 | $21.77M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $11.09M derived: sum of 2 quarters · filed 2024-03-28 | $15.63M derived: sum of 3 quarters · filed 2024-03-28 | $20.29M 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.55M derived: sum of 2 quarters · filed 2023-11-08 | $15.21M 10-Q · filed 2023-11-08 | $13.21M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.20M 10-Q · filed 2023-08-09 | $7.20M derived: sum of 3 quarters · filed 2023-08-09 | $9.60M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $4.66M 10-Q · filed 2023-05-10 | $2.66M derived: sum of 2 quarters · filed 2023-05-10 | $5.06M derived: sum of 3 quarters · filed 2023-05-10 | $6.30M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $401.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.65M derived: sum of 3 quarters · filed 2023-03-16 | $2.19M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.65M derived: sum of 2 quarters · filed 2022-11-09 | $4.20M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.79M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $550.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $6.76M 10-K · filed 2022-03-11 |